3 insiders reported 3 Form 4 transactions for Raphael Pharmaceutical Inc. (RAPH) over the past 18 months (most recent 2026-04-06). Recent activity: Louria Hayon Igal (Chief Technology Officer) Buy 350,000 shares, Pilo Shlomo (Chief Executive Officer) Buy 200,000 shares, Dhadha Ajay Kumar (Director) Buy 350,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-06 | Louria Hayon Igal | Chief Technology Officer | Buy | 350,000 | $3,500 |
| 2025-03-11 | Pilo Shlomo | Chief Executive Officer | Buy | 200,000 | $100,000 |
| 2025-03-06 | Dhadha Ajay Kumar | Director | Buy | 350,000 | $0 |
Source: SEC Form 4 filings · as of 2026-04-06
